HomeCompareGNFT vs PEP

GNFT vs PEP: Dividend Comparison 2026

GNFT yields 22.35% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEP wins by $57.7K in total portfolio value· pulled ahead in Year 9
10 years
GNFT
GNFT
● Live price
22.35%
Share price
$8.95
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$84.2K
Annual income
$8,592.87
Full GNFT calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — GNFT vs PEP

📍 PEP pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGNFTPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GNFT + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GNFT pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GNFT
Annual income on $10K today (after 15% tax)
$1,899.44/yr
After 10yr DRIP, annual income (after tax)
$7,303.94/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, PEP beats the other by $45,290.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GNFT + PEP for your $10,000?

GNFT: 50%PEP: 50%
100% PEP50/50100% GNFT
Portfolio after 10yr
$113.1K
Annual income
$35,234.27/yr
Blended yield
31.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

GNFT
Analyst Ratings
6
Buy
1
Sell
Consensus: Buy
Price Target
$13.00
+45.3% upside vs current
Range: $13.00 — $13.00
Altman Z
-0.1
Piotroski
2/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GNFT buys
0
PEP buys
0
No recent congressional trades found for GNFT or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGNFTPEP
Forward yield22.35%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$84.2K$141.9K
Annual income after 10y$8,592.87$61,875.67
Total dividends collected$50.6K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusBuyHold
Analyst price target$13.00$172.43

Year-by-year: GNFT vs PEP ($10,000, DRIP)

YearGNFT PortfolioGNFT Income/yrPEP PortfolioPEP Income/yrGap
1$12,935$2,234.64$10,849$509.42+$2.1KGNFT
2$16,541$2,701.33$11,969$750.47+$4.6KGNFT
3$20,928$3,228.58$13,500$1,124.14+$7.4KGNFT
4$26,210$3,817.51$15,680$1,721.66+$10.5KGNFT
5$32,513$4,468.32$18,929$2,715.34+$13.6KGNFT
6$39,970$5,180.24$24,023$4,450.80+$15.9KGNFT
7$48,719$5,951.60$32,510$7,669.92+$16.2KGNFT
8$58,909$6,779.83$47,709$14,093.60+$11.2KGNFT
9← crossover$70,694$7,661.60$77,415$28,083.48$6.7KPEP
10$84,236$8,592.87$141,922$61,875.67$57.7KPEP

GNFT vs PEP: Complete Analysis 2026

GNFTStock

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

Full GNFT Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this GNFT vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GNFT vs SCHDGNFT vs JEPIGNFT vs OGNFT vs KOGNFT vs MAINGNFT vs MOGNFT vs PMGNFT vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.